Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6148)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2014 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Farzand S, Siddique T, Saba K, Bukhari MH. Frequency of HER2/neu overexpression in adenocarcinoma of the gastrointestinal system. World J Gastroenterol 2014; 20(19): 5889-5896 [PMID: 24914350 DOI: 10.3748/wjg.v20.i19.5889] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i19/5889.htm |
| Number | Citing Articles |
| 1 |
Heba A. Sayed, Abeer Refaiy, Mohammed A. Salem. Prognostic Impact of HER/2 Expression on Survival of Preoperatively Treated Children with Wilms Tumor at South Egypt. Journal of Cancer Therapy 2017; 8(09): 801 doi: 10.4236/jct.2017.89070
|
| 2 |
Susnata Khan, Senjuti Dasgupta, Asit Ranjan Deb. Colorectal Carcinoma: Is There Any Correlation between Her2/neu Expression, Ki-67 Score, and Tumor Budding and Clinicopathological Parameters?—A Prospective Institution-Based Study. South Asian Journal of Cancer 2024; doi: 10.1055/s-0044-1789276
|
| 3 |
Renuka Patil, Shanthala P R, Prema Saldanha. IMMUNOHISTOCHEMICAL MARKERS OF CLINICAL SIGNIFICANCE IN CARCINOMA OF THE COLON AND RECTUM. Journal of Evolution of Medical and Dental Sciences 2016; 5(96): 7087 doi: 10.14260/jemds/2016/1603
|
| 4 |
Danielle Benedict Sacdalan, Marvin Jonne Mendoza, John Paulo Vergara, Lance Isidore Catedral, Frederic Ivan Ting, Louis Mervyn Leones, Carlo Miguel Berba, Dennis L. Sacdalan. Beyond bevacizumab: a review of targeted agents in metastatic small bowel adenocarcinoma. Medical Oncology 2020; 37(11) doi: 10.1007/s12032-020-01432-3
|
| 5 |
Jung-Soo Pyo, Guhyun Kang, Kyeongmee Park. Clinicopathological Significance and Diagnostic Accuracy of HER2 Immunohistochemistry in Colorectal Cancer: A Meta-Analysis. The International Journal of Biological Markers 2016; 31(4): 389 doi: 10.5301/jbm.5000208
|
| 6 |
Valentina Fanotto, Elena Ongaro, Karim Rihawi, Antonio Avallone, Nicola Silvestris, Lorenzo Fornaro, Enrico Vasile, Lorenzo Antonuzzo, Francesco Leone, Gerardo Rosati, Francesco Giuliani, Roberto Bordonaro, Mario Scartozzi, Giovanna De Maglio, Francesca V. Negri, Gianpiero Fasola, Giuseppe Aprile. HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives. Oncotarget 2016; 7(42): 69060 doi: 10.18632/oncotarget.11264
|
| 7 |
Shipra Singh, Kailash Chand Jat, Ajit Singh, Kunal Purohit. A STUDY OF HISTOPATHOLOGICAL DISTRIBUTION IN COLORECTAL CANCER. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2021; : 24 doi: 10.36106/ijsr/0306321
|
| 8 |
Seyed-Hamid Madani, Edris Sadeghi, Akram Rezaee, Masoud Sadeghi, Sedigheh Khazaee, Nasrin Amirifard, Mehrdad Payandeh. Survey of HER2-neu Expression in Colonic Adenocarcinoma in the West of Iran. Asian Pacific Journal of Cancer Prevention 2015; 16(17): 7671 doi: 10.7314/APJCP.2015.16.17.7671
|
| 9 |
Asma Shabbir, Talat Mirza, Abdullah Bin Khalid, Muhammad Asif Qureshi, Sadaf Ahmed Asim. Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2912-y
|
| 10 |
Peng Ye, Fanghua Li, Yuanyuan Wei, Yihao Zhang, Jianing Cui, Rui Dai, Hao Chen, Jing Xie, Peiling Cai. EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-17210-2
|
| 11 |
Ritu Jangir, Ajay Sharma, Anjali Sharma, Rateesh Sareen. STUDY OF HER2 NEU POSITIVITY IN GASTROINTESTINAL CANCERS AT A TERTIARY CARE HOSPITAL IN INDIA. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2021; : 7 doi: 10.36106/ijsr/7517525
|
| 12 |
Anna La Salvia, Victoria Lopez-Gomez, Rocio Garcia-Carbonero. HER2-targeted therapy: an emerging strategy in advanced colorectal cancer. Expert Opinion on Investigational Drugs 2019; 28(1): 29 doi: 10.1080/13543784.2019.1555583
|
| 13 |
Serkan Yaşar ÇELİK, Leyla TEKİN. Kolorektal Kanserlerde HER-2/neu Ekspresyonunun Histopatolojik ve Prognostik Parametrelerle Korelasyonu. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi 2020; 7(3): 145 doi: 10.47572/muskutd.767857
|
| 14 |
Zeinab Faghfoori, Bahram Pourghassem Gargari, Amir Saber, Maryam Seyyedi, Siavash Fazelian, Ahmad Yari Khosroushahi. Prophylactic effects of secretion metabolites of dairy lactobacilli through downregulation of ErbB-2 and ErbB-3 genes on colon cancer cells. European Journal of Cancer Prevention 2020; 29(3): 201 doi: 10.1097/CEJ.0000000000000393
|
| 15 |
Harshabad Singh, Ashley Kang, Lisa Bloudek, Ling-I Hsu, Maria Corinna Palanca-Wessels, Michael Stecher, Muriel Siadak, Kimmie Ng. Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancer. JNCI Cancer Spectrum 2024; 8(1) doi: 10.1093/jncics/pkad082
|